Project ASTEROID
-
EIC Accelerator 2024
ASTEROID project, a multiorgan toxicity and efficacy test platform for personalized medicine & drug development
Explore how the asteroid project aims at resolving the technological bottlenecks for drug development & personalized medicine
Objectives
- Finalize the development of the Asteroid project platform from a viable demonstrator (TRL6) to a system complete and qualified in an operational environment (TRL8)
- Develop and enrich the Cherry Bio AppStore, our catalog of new 3D cell culture protocols, with new bio-applications for distribution
- Qualify and market our Asteroid project platform for research use only (RuO) and, in the long term, develop the platform as companion diagnostic (CDx)
Our Role
As project sole partner and leader, Cherry Biotech will ensure project implementation. The Asteroid project will further develop and qualify the multiorgan toxicity and efficacy test platform with KOL partners. The pathway to deployment is divided into 3 interconnected work packages:
- Work Package 1: Final design Asteroid multiorgan toxicity and efficacy test platform
- Work Package 2: Development of RUO organ model kits
- Work Package 3: Project management and administration
Expected Results
A ready-to-market fully completed and qualified platform including hardware and software, made available to solve the most common scientific and industrial bottlenecks in existing 3D culture systems for preclinical drug development and precision medicine
A catalog of validated, in-house biological model protocols available through Cherry BioAppStore, designed to serve as a foundation for future outsourced development of fit-for-purpose (FFP) protocols through collaborative user engagement
Development of the platform as CDx and finalizing the commercialization strategy
This project has been funded by The European Union, under the grant agreement n° 101189261.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
start a project with us
Our expertise combines Microfluidic, 3DCell culture, Microscopy, Omics and artificial intelligence.
Let’s get intouch to see how we can collaborate for future projects